Cell Cryopreservation Market: By Product Type (Cryoprotectant Agents, Equipment), By Cell Types (Stem cells, Oocytes and embryotic cells, Sperm cells, Hepatocytes, Other Cell Types), By Application (Drug Discovery and Development, Regenerative Medicine, Organ Transplantation, Clinical Research, Other Applications), By End Users (Research Organizations, Biotech/ Pharmaceutical Companies, Contract Research Organizations (CROs), Hospitals and Clinics) and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America) and forecast to 2030.

Cell Cryopreservation Market size was valued at USD 9,746.3 million in 2023 and is poised to grow at a CAGR of 21.3% from 2024-2030. Cell cryopreservation is a process used to preserve cells, tissues, or any other biological constructs by cooling them to very low temperatures. At such low temperatures, any biological activity is effectively halted. Cryoprotectants are substances used to protect biological tissue from freezing damage. They work by preventing the formation of ice crystals. Once frozen, cells are stored at cryogenic temperatures, usually in liquid nitrogen at temperatures of -196°C. Rising awareness and adoption of fertility preservation techniques, especially among women wishing to delay childbearing or facing fertility issues, are driving the demand for cryopreservation solutions. According to the Society for Assisted Reproductive Technology (SART), in the United States alone, the number of egg freezing cycles increased from 7,193 in 2016 to 12,438 in 2020, reflecting a growth rate of approximately 73% over that period. Moreover, advances in stem cell therapies and regenerative medicine, the establishment of new biobanks and the rising demand for personalized medicine are the main drivers of this market. In addition, WHO also emphasis the importance of the cell cryopreservation and best practices. During COVID-19, the worthiness of the cell cryopreservation is noted as this technology helped in maintaining vaccine production. The most important and crucial constraints of this market is the initial investment and ongoing maintenance costs for cryopreservation equipment and storage facilities. Also concerns from the recipient side is the cryoprotectant toxicity. Some cryoprotectants, like DMSO, can be toxic to cells at certain concentrations, posing challenges in optimizing protocols for different cell types. Every market has it’s own challenges, as this one has are regulatory and ethical issues faced by the companies, storage and transportation of the preserved cell samples.

Recent Development In The Cell Cryopreservation Market :

• In June 2023, BioLife Solutions, Inc. announced the launch of a new large-capacity controlled-rate freezer (CRF) to expand its CRF product line.
• In 2022, AMSBIO has introduced 'STEM-CELLBANKER EX,' a state-of-the-art cryopreservation solution designed to accelerate the development of cell therapy products.
• In March 2022, Eppendorf Corporate redesigned the CryoCubeF570 ULT freezer with improved cooling liquids and insulation foam